BIOMAT Database Logo BIOMAT Database Logo

[A fifty two-week oral repeated dose toxicity study of suplatast tosilate (IPD-1151T) in dogs]. 1992

M Aoki, and T Ohtaki, and T Seki, and K Kojima, and S Yoshimura, and H Ikeda, and H Kawaguchi, and H Katsumura, and K Yamaguchi, and H Inada
Hatano Research Institute, Food and Drug Safety Center, Kanagawa, Japan.

A 52-week oral repeated dose toxicity study of suplatast tosilate (IPD-1151T), a newly developed anti-allergic agent, was carried out in beagles by oral administration of 30, 90, 270 and 810 mg/kg/day for 52 weeks. The recovery study was carried out by the withdrawal for 5 weeks using control and the 810 mg/kg groups. The results are as follows: 1. Observation of general conditions revealed soft feces, mucous feces, and diarrhea in both sexes of the 270 and 810 mg/kg groups during the administration period, and these findings disappeared during the withdrawal period. One female of the 810 mg/kg group exhibited tremors in the legs and neck, staggering, a decrease of spontaneous motor activity, and clonic convulsions in Week 17 of administration and died on Day 118. One male of the same group exhibited whole body tremors and staggering from Week 32 to Week 52. 2. Body weight gain tended to be inhibited in males of the 810 mg/kg group during the administration period. The body weight of the female that died decreased rapidly after the appearance of neurological symptoms. The body weight of the male that exhibited neurological symptoms decreased after their appearance but later increased. 3. There were no abnormal changes in food consumption in all of the sacrificed dogs. The female that died did not eat at all after the appearance of neurological symptoms. The male that exhibited neurological symptoms did not eat at all for 1 week after their appearance, but the food consumption returned to normal thereafter. 4. Prothrombin times were prolonged in males of the 270 and 810 mg/kg groups at Week 26, and activated partial thromboplastin times were prolonged in males of the 810 mg/kg group at Week 52. 5. Plasma levels of alkaline phosphatase, GPT and LDH were elevated in some males and females of the 810 mg/kg groups. 6. No abnormalities due to IPD-1151T administration were found in urinalysis, opthalmological examination, electrocardiography, and fecal occult blood examination, or organ weights. 7. Autopsies including histopathological and electron microscopic examinations on the sacrificed dogs revealed no abnormalities. Subserosal hemorrhage in the base of the heart, congestion in the lungs, congestion and vacuolation in the liver and slight cell infiltration around vessels of the brain were found in the female that died.(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females
D006633 Histamine Antagonists Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. Antihistamine,Antihistamines,Histamine Antagonist,Antagonist, Histamine,Antagonists, Histamine
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001190 Arylsulfonates Organic sulfonic acid esters or salts which contain an aromatic hydrocarbon radical. Aryl Sulfonates,Sulfonates, Aryl
D013452 Sulfonium Compounds Sulfur compounds in which the sulfur atom is attached to three organic radicals and an electronegative element or radical. Sulfine Compounds,Compounds, Sulfine,Compounds, Sulfonium

Related Publications

M Aoki, and T Ohtaki, and T Seki, and K Kojima, and S Yoshimura, and H Ikeda, and H Kawaguchi, and H Katsumura, and K Yamaguchi, and H Inada
[A thirteen-week oral repeated dose toxicity study of suplatast tosilate (IPD-1151T) in dogs].
May 1992, The Journal of toxicological sciences,
M Aoki, and T Ohtaki, and T Seki, and K Kojima, and S Yoshimura, and H Ikeda, and H Kawaguchi, and H Katsumura, and K Yamaguchi, and H Inada
[A fifty-two week oral chronic toxicity study of suplatast tosilate (IPD-1151T) in rats].
May 1992, The Journal of toxicological sciences,
M Aoki, and T Ohtaki, and T Seki, and K Kojima, and S Yoshimura, and H Ikeda, and H Kawaguchi, and H Katsumura, and K Yamaguchi, and H Inada
[A thirteen-week oral repeated dose toxicity study of suplatast tosilate (IPD-1151T) in rats].
May 1992, The Journal of toxicological sciences,
M Aoki, and T Ohtaki, and T Seki, and K Kojima, and S Yoshimura, and H Ikeda, and H Kawaguchi, and H Katsumura, and K Yamaguchi, and H Inada
[Single dose toxicity studies of suplatast tosilate (IPD-1151T)].
May 1992, The Journal of toxicological sciences,
M Aoki, and T Ohtaki, and T Seki, and K Kojima, and S Yoshimura, and H Ikeda, and H Kawaguchi, and H Katsumura, and K Yamaguchi, and H Inada
[Antigenicity tests of suplatast tosilate (IPD-1151T)].
May 1992, The Journal of toxicological sciences,
M Aoki, and T Ohtaki, and T Seki, and K Kojima, and S Yoshimura, and H Ikeda, and H Kawaguchi, and H Katsumura, and K Yamaguchi, and H Inada
[Mutagenicity tests of suplatast tosilate (IPD-1151T)].
May 1992, The Journal of toxicological sciences,
M Aoki, and T Ohtaki, and T Seki, and K Kojima, and S Yoshimura, and H Ikeda, and H Kawaguchi, and H Katsumura, and K Yamaguchi, and H Inada
Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation.
March 2007, The Journal of urology,
M Aoki, and T Ohtaki, and T Seki, and K Kojima, and S Yoshimura, and H Ikeda, and H Kawaguchi, and H Katsumura, and K Yamaguchi, and H Inada
[Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (3)--Teratological study in rabbits by oral administration].
May 1992, The Journal of toxicological sciences,
M Aoki, and T Ohtaki, and T Seki, and K Kojima, and S Yoshimura, and H Ikeda, and H Kawaguchi, and H Katsumura, and K Yamaguchi, and H Inada
[Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (1)--Fertility study in rats by oral administration].
May 1992, The Journal of toxicological sciences,
M Aoki, and T Ohtaki, and T Seki, and K Kojima, and S Yoshimura, and H Ikeda, and H Kawaguchi, and H Katsumura, and K Yamaguchi, and H Inada
[Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (2)--Teratological study in rats by oral administration].
May 1992, The Journal of toxicological sciences,
Copied contents to your clipboard!